SCHEMBL1660865

SCHEMBL1660865

NC(Cc1c(F)cccc1F)C(=O)O.NC(Cc1ccccc1F)C(=O)O.NC(Cc1ccccc1F)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.50
NOS1 P29475 3/20 0.50
NOS2 P35228 3/20 0.50
PKM P14618 2/20 0.50
ALPI P09923 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
PTPN1 P18031 1/20 0.50
USP2 O75604 2/20 0.46
HIF1A Q16665 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
BLM P54132 2/20 0.46
PMP22 Q01453 2/20 0.46
KMT2A Q03164 2/20 0.46
RGS12 O14924 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660868 1.00 NOS3 (0.50) NOS3NOS1NOS2PKMALPI
SCHEMBL44126 0.92 PKM (0.58) NOS3NOS1NOS2PKMALPI
SCHEMBL29401250 0.92 PKM (0.58) NOS3NOS1NOS2PKMALPI
SCHEMBL268942 0.92 PKM (0.58) NOS3NOS1NOS2PKMALPI
SCHEMBL44127 0.92 PKM (0.58) NOS3NOS1NOS2PKMALPI
Hydrochloric Acid SCHEMBL27128716 0.90 PKM (0.56) NOS3NOS1NOS2PKMALPI
Hydrochloric Acid SCHEMBL27515071 0.90 PKM (0.56) NOS3NOS1NOS2PKMALPI
Hydrochloric Acid SCHEMBL26985803 0.90 PKM (0.56) NOS3NOS1NOS2PKMALPI
SCHEMBL188588 0.90 SLC7A5 (0.55) NOS3NOS1NOS2PKMALPI
SCHEMBL188587 0.90 SLC7A5 (0.55) NOS3NOS1NOS2PKMALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491054-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST Cadila Healthcare Limited (IN) 2012-08-29 EP disclosed
WO-2011048614-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST CADILA HEALTHCARE LIMITED (IN) 2011-04-28 WO disclosed
EP-2084182-A2 ANTIDIABETIC COMPOUNDS Cadila Healthcare Limited (IN) 2009-08-05 EP disclosed
WO-2008062457-A2 ANTIDIABETIC COMPOUNDS CADILA HEALTHCARE LIMITED (IN) 2008-05-29 WO disclosed